Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Marinescu Daniel-Costin, Raghu Ganesh, Remy-Jardin Martine, Travis William D, Adegunsoye Ayodeji, Beasley Mary Beth, Chung Jonathan H, Churg Andrew, Cottin Vincent, Egashira Ryoko, Fernández Pérez Evans R, Inoue Yoshikazu, Johannson Kerri A, Kazerooni Ella A, Khor Yet H, Lynch David A, Müller Nestor L, Myers Jeffrey L, Nicholson Andrew G, Rajan Sujeet, Saito-Koyama Ryoko, Troy Lauren, Walsh Simon L F, Wells Athol U, Wijsenbeek Marlies S, Wright Joanne L, Ryerson Christopher J
Аннотация
Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines were developed independently, without clear direction on how to apply their respective recommendations concurrently within a single patient, where discrimination between these two fibrotic interstitial lung diseases represents a frequent diagnostic challenge. The objective of this review, created by an international group of experts, was to suggest a pragmatic approach on how to apply existing guidelines to distinguish IPF and fHP. Key clinical, radiologic, and pathologic features described in previous guidelines are integrated in a set of diagnostic algorithms, which then are placed in the broader context of multidisciplinary discussion to guide the generation of a consensus diagnosis. Although these algorithms necessarily reflect some uncertainty wherever strong evidence is lacking, they provide insight into the current approach favored by experts in the field based on currently available knowledge. The authors further identify priorities for future research to clarify ongoing uncertainties in the diagnosis of fibrotic interstitial lung diseases.